Episode

HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach

Podcast
Lung Cancer Update
Published
Dec 10, 2025
Duration seconds
3913
Processing state
not_requested
Canonical source
https://lung-cancer-update.captivate.fm/episode/5684-oncologytodayheralterednsclc25
Audio
https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/4b99109a-423f-4ca4-8d02-fbfc9e590dc0.mp3
JSON
/v1/public/podcasts/lung-cancer-update-827388/episodes/her2-altered-non-small-cell-lung-cancer-an-interview-with-dr-john-v-heymach
Markdown
/podcast/lung-cancer-update-827388/her2-altered-non-small-cell-lung-cancer-an-interview-with-dr-john-v-heymach.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/her2-altered-non-small-cell-lung-cancer-an-interview-with-dr-john-v-heymach/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/lung-cancer-update-827388/her2-altered-non-small-cell-lung-cancer-an-interview-with-dr-john-v-heymach.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr John Heymach from The University of Texas MD Anderson Cancer Center in Houston discusses recent updates on available and novel treatment strategies for HER2-altered non-small cell lung cancer.    CME information and select publications here .